Related Experiment Video
Updated: Jun 16, 2026
12:55
P50 Sensory Gating in Infants
Published on: December 26, 2013
P50 gating in deficit and nondeficit schizophrenia
José Luis Santos1, Eva María Sánchez-Morla, Ana Aparicio
1Department of Psychiatry, Hospital Virgen de la Luz, Cuenca, Spain.
Schizophrenia Research
|February 16, 2010
Summary
Schizophrenia patients show impaired auditory sensory processing, specifically in P50 gating. This deficit, common in both deficit and non-deficit schizophrenia, correlates with poorer functional outcomes.
Area of Science:
- Neuroscience
- Psychiatry
- Auditory Processing
Background:
- Schizophrenia is often associated with dysfunctional auditory sensory processing.
- These auditory deficits may link to clinical and psychosocial factors.
Purpose of the Study:
- To investigate auditory sensory processing using P50 recordings in schizophrenia patients.
- To compare P50 gating between deficit schizophrenia (DS) and non-deficit schizophrenia (NDS) patients and controls.
Main Methods:
- Utilized a simple-paired click auditory evoked potential paradigm for P50 recordings.
- Sixty DS patients, sixty NDS patients, and sixty controls participated.
- The Schedule for the Deficit Syndrome classified patients into DS or NDS groups.
Main Results:
- Both DS and NDS groups exhibited impaired P50 gating ratios compared to controls (p<0.0001).
- No significant P50 ratio differences were found between DS and NDS subgroups.
- Impaired P50 gating correlated with poorer community outcome, independent of symptom severity.
Conclusions:
- Early auditory sensory processing abnormalities exist in both DS and NDS.
- Common neuronal network dysfunction may underlie both forms of schizophrenia.
- Deficient P50 gating is potentially linked to impaired functional outcomes in schizophrenia.
Related Concept Videos
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:30Negative and Cognitive Symptoms of Schizophrenia
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:30Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...